Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.
Top Providers in California
| Provider | Medicare | Services |
|---|---|---|
| Neogenomics Laboratories Inc | $51.34 | 240 |
| Neogenomics Laboratories Inc | $50.55 | 176 |
| Neogenomics Laboratories Inc | $52.10 | 165 |
| Neogenomics Laboratories Inc | $50.87 | 79 |
| Wong, Hannah M.D. | $49.17 | 50 |
| Said, Jonathan MD | $53.31 | 45 |
| Quest Diagnostics Nichols Institute | $52.10 | 29 |
| Song, Sophie MD | $53.31 | 28 |
| Pullarkat, Sheeja MD | $53.31 | 28 |
| Danilova, Olga M.D., PH.D. | $52.14 | 26 |
| Aoun, Patricia MD | $52.14 | 25 |
| Pacific Diagnostic Laboratories | $51.27 | 17 |
| Lopategui, Jean Marie MD | $53.31 | 16 |
| Cytometry Specialists, Inc. | $52.10 | 16 |
| Kitahara, Sumire M.D. | $51.83 | 16 |
| Gemini Diagnostics Inc | $51.41 | 15 |
| Igenex Inc | $54.88 | 15 |
| Johnson, Rebecca M.D. | $46.08 | 11 |
California Pricing in Context
In California, CPT code 88188 (Flow Cytometry Technique For Dna Or Cell Analysis, 9 To 15 Markers) carries an average Medicare payment of $52.53 — 9% above the national benchmark of $48.39. 165 providers across the state submitted claims for this procedure in 2023, performing 3.5K total services. Individual payments in CA ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.
The average billed charge in California is $335.15, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because California sits above the national Medicare average, commercial rates in the state may also run higher than the US median.
Using RAND 2024 commercial-to-Medicare ratios for Genetic/Molecular Test procedures, the estimated commercial insurance price in California lands near $159.96, with self-pay cash prices typically around $142.15. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.
Frequently Asked Questions
How much does Flow Cytometry Technique For Dna Or Cell Analysis, 9 To 15 Markers cost in California?
The average Medicare payment for Flow Cytometry Technique For Dna Or Cell Analysis, 9 To 15 Markers in California is $52.53, which is 9% above the national average of $48.39. Providers in CA typically bill $335.15 for this procedure.
What does Flow Cytometry Technique For Dna Or Cell Analysis, 9 To 15 Markers cost with insurance in California?
With commercial insurance in California, Flow Cytometry Technique For Dna Or Cell Analysis, 9 To 15 Markers costs an estimated $159.96. Without insurance, the estimated cash price is $142.15. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.
How many providers perform Flow Cytometry Technique For Dna Or Cell Analysis, 9 To 15 Markers in California?
165 providers in California billed Medicare for Flow Cytometry Technique For Dna Or Cell Analysis, 9 To 15 Markers in 2023, performing 3.5K total services. Medicare payments ranged from N/A to N/A depending on the provider.
Is Flow Cytometry Technique For Dna Or Cell Analysis, 9 To 15 Markers cheaper in California than the national average?
No — Flow Cytometry Technique For Dna Or Cell Analysis, 9 To 15 Markers costs 9% above the national average in California. The state average Medicare payment is $52.53 compared to $48.39 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.
Related Guides
Related Data Sources
Data from CMS Medicare Physician & Other Practitioners (2023).
Read our methodology — how this data is sourced, computed, and verified.